Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity
Manufacturer Supply with High Purity and Stable Quality
Chemical Name: Lasofoxifene Tartrate
CAS: 190791-29-8
Lasofoxifene Tartrate (CAS: 190791-29-8) in the treatment of Postmenopausal Osteoporosis
Chemical Name | Lasofoxifene Tartrate |
Synonyms | (5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate Oporia |
CAS Number | 190791-29-8 |
CAT Number | RF-API20 |
Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
Molecular Formula | C28H31NO2.ClH |
Molecular Weight | 450.019 |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Off-White Powder |
Moisture (K.F) | ≤0.50% |
Heavy Metals | ≤20ppm |
Chiral Purity | ≥99.0% |
Purity / Analysis Method | ≥98.0% (HPLC) |
Loss on Drying | ≤0.50% |
Residue on Ignition | ≤0.50% |
Test Standard | Chinese Pharmacopoeia (CP); Enterprise Standard |
Usage | Active Pharmaceutical Ingredient (API); Postmenopausal Osteoporosis |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Lasofoxifene Tartrate (CAS: 190791-29-8) with high quality.
Lasofoxifene Tartrate is a third-generation, non-steroidal selective estrogen receptor modulator (SERM). It selectively binds to human ERalpha with an IC50 value of 1.5 nM and inhibits bone loss in ovariectomized rats. In clinical studies of postmenopausal osteoporosis, 0.5 mg/day lasofoxifene was associated with reduced risks of nonvertebral and vertebral fractures, ER-positive breast cancer, coronary heart disease, and stroke but an increased risk of venous thromboembolic events. Lasofoxifene has also been shown to act as an inverse agonist at the CB2 cannabinoid receptor, indicating its potential to be repurposed as a therapeutic for indications wherein CB2 is a target.
-
Lasofoxifene Tartrate CAS 190791-29-8 Chiral Pu...
-
Sorafenib Tosylate CAS 475207-59-1 Purity ≥99.0...
-
CAS 274901-16-5 Purity ≥99.0% (HPLC) API
-
Vonoprazan Fumarate (TAK-438) CAS 1260141-27-2 ...
-
Abacavir CAS 136470-78-5 Assay 99.0%~101.0% API...
-
Abacavir Sulfate CAS 188062-50-2 Assay 98.0%~10...
-
Acotiamide Hydrochloride Trihydrate CAS 773092-...
-
Acyclovir CAS 59277-89-3 API Factory Antiviral ...
-
CAS 665-66-7 Assay 98.5%~101.5% API
-
Anastrozole CAS 120511-73-1 API Factory High Qu...
-
Argatroban CAS 74863-84-6 API Factory High Puri...
-
Argatroban Monohydrate CAS 141396-28-3 Purity ≥...
-
Atazanavir CAS 198904-31-3 Purity ≥99.0% API Fa...
-
Atazanavir Sulfate CAS 229975-97-7 Purity ≥99.0...
-
Azelastine Hydrochloride CAS 79307-93-0 Assay 9...
-
Azithromycin Dihydrate CAS 117772-70-0 Assay 94...